Metastatic disease in the cerebellum: The LSU experience in 1981-1993

Federico L. Ampil, Anil Nanda, Brian K. Willis, Indrani Nandy, Rosemary Meehan

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

We retrospectively determined the outcome of management of metastatic disease in the cerebellum (MDC) in 45 patients because MDC is considered to be more immediately life-threatening than metastases in other intracranial locations. Treatment consisted of tumor resection and radiotherapy (RR; n = 11) or of radiotherapy alone (RA; n =34). Significant differences in the median survival (15 months for RR and 3 months for RA, p = 0.005) and in survival rates at 1 year (61 ± 30% for RR and 9 ± 10% for RA, p < 0.001) and at 2 years (15 ± 22% for RR and 0% for RA, p < 0.05) were noted. This combined management program of surgery followed by radiotherapy for MDC produced a worthwhile gain in survival.

Original languageEnglish (US)
Pages (from-to)509-511
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume19
Issue number5
DOIs
StatePublished - Sep 30 1996
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Cerebellum
  • Metastasis
  • Radiotherapy
  • Surgery

Fingerprint Dive into the research topics of 'Metastatic disease in the cerebellum: The LSU experience in 1981-1993'. Together they form a unique fingerprint.

Cite this